Bangalore: Biocon has announced that Biocon Pharma Limited, a wholly owned subsidiary of the Company, in partnership with ...
Rotavirus causes severe dehydrating diarrhea in infants and young children, contributing to more than 128,500 deaths per year ...
Starting now — with Halloween treats beckoning indulgence — excessive sugar consumption rises and continues through the ...
Biocon said that Biocon Pharma, in partnership with Carnegie Pharmaceuticals LLC, has received tentative approval from the U.S. Food and Drug Administration (U.S. FDA) for the ANDA for Rifaximin ...
Early on Oct. 7, 2023, Hamas-led fighters launched a multipronged terrorist attack on Israel. The resulting war in Gaza has ...
Macon Telegraph on MSN
She died by suicide in Wilkinson County Jail. Her family is now suing
The lack of care at the jail led to the detainee’s death, the lawsuit alleges. The woman had been detained for seven days ...
News-Medical.Net on MSN
Discovery opens up new avenues for treating rotavirus infections
Rotavirus causes severe dehydrating diarrhea in infants and young children, contributing to more than 128,500 deaths per year globally despite widespread vaccination efforts. Although rotavirus is ...
Rifaximin tablets are a rifamycin antibacterial indicated for reducing the risk of overt hepatic encephalopathy (HE) recurrence and to treat irritable bowel syndrome with diarrhea (IBS-D) in adults.
News-Medical.Net on MSN
$4 million grant supports effort to turn enzyme-targeting science into treatments for Cryptosporidium infections
A University of Houston professor has received nearly $4 million in new support from the National Institute of Allergy and Infectious Diseases to lead a translational effort turning enzyme-targeting ...
Tuko News on MSN
Narok: Cholera Outbreak Claims 5 Lives, Authorities Shut Down Eateries to Contain Spread
Narok cholera outbreak kills five people, with 45 hospitalised as Narok County government moves to shut markets and food stalls to curb further spread.
Detailed price information for Astrazeneca Plc ADR (AZN-Q) from The Globe and Mail including charting and trades.
Additional Transaction Details Under the terms of the acquisition agreement, Merck, through a subsidiary, has acquired all outstanding shares of Verona Pharma for $107 per ADS, each of which ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results